المؤلفون: C. F. Murillo Perez, J. C. Goet, W. J. Lammers, A. Gulamhusein, H. R. van Buuren, C. Y. Ponsioen, M. Carbone, A. Mason C. Corpechot, P. Invernizzi, M. J. Mayo, P. M. Battezzati, A. Floreani, A. Pares, F. Nevens, K. V. Kowdley, T. Bruns, G. N. Dalekos, D. Thorburn, G. Hirschfield, N. F. LaRusso, K. D. Lindor, K. Zachou, R. Poupon, P. J. Trivedi, X. Verhelst, H. L. A. Janssen, B. E. Hansen

المساهمون: C.F. Murillo Perez, J.C. Goet, W.J. Lammer, A. Gulamhusein, H.R. van Buuren, C.Y. Ponsioen, M. Carbone, A.M.C. Corpechot, P. Invernizzi, M.J. Mayo, P.M. Battezzati, A. Floreani, A. Pare, F. Neven, K.V. Kowdley, T. Brun, G.N. Daleko, D. Thorburn, G. Hirschfield, N.F. Larusso, K.D. Lindor, K. Zachou, R. Poupon, P.J. Trivedi, X. Verhelst, H.L.A. Janssen, B.E. Hansen

مصطلحات موضوعية: Primary sclerosing cholangiti, ursodeoxycholic acid therapy, noth-east England, biochemical response, histological progression, symptom progression, clinical-feature, treated patient, follow-up, cirrhosis, Settore MED/09 - Medicina Interna, Settore MED/12 - Gastroenterologia

Relation: info:eu-repo/semantics/altIdentifier/pmid/29220537; info:eu-repo/semantics/altIdentifier/wos/WOS:000430388500025; volume:67; issue:5; firstpage:1920; lastpage:1930; numberofpages:11; journal:HEPATOLOGY; http://hdl.handle.net/2434/629661; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85044857427

الاتاحة: http://hdl.handle.net/2434/629661
https://doi.org/10.1002/hep.29717

المؤلفون: Fatema Alalkim, Benedetta Terziroli Beretta-Piccoli, Thomas Berg, Cumali Efe, Fulya Gunsar, Ellina Lytvyak, Janett Fischer, Fredrik Rorsman, Ali Riza Caliskan, Hanns-Ulrich Marschall, Kristina Önnerhag, Tugrul Purnak, Ida Henriksson, Maneerat Chayanupatkul, Claudia Coppo, Can Gonen, David Semela, Staffan Wahlin, Murat Kiyici, Ersan Ozaslan, Alexandra Heurgué-Berlot, Emma Nilsson, Alan Bonder, Koray Tascilar, Luigi Muratori, Fatih Güzelbulut, Murat Aladağ, Aldo J. Montano-Loza, Fatih Eren, Mårten Werner, Nurhan Demir, Henriette Ytting, Paolo Muratori, Thomas D. Schiano, Hirsh D. Trivedi, Eric M. Yoshida, Johanna Eliasson

المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri., Eren, Fatih, AAS-6286-2020, Ege Üniversitesi, Efe C., Tascilar K., Henriksson I., Lytvyak E., Alalkim F., Trivedi H., Eren F., Eliasson J., Beretta-Piccoli B.T., Fischer J., Caliskan A.R., Chayanupatkul M., Coppo C., Ytting H., Purnak T., Muratori L., Werner M., Muratori P., Rorsman F., Onnerhag K., Gunsar F., Nilsson E., Heurgue-Berlot A., Guzelbulut F., Demir N., Gonen C., Semela D., Aladag M., Kiyici M., Schiano T.D., Montano-Loza A.J., Berg T., Ozaslan E., Yoshida E.M., Bonder A., Marschall H.-U., Wahlin S.

مصطلحات موضوعية: Male, Scoring system, Survival rate, Kaplan Meier method, Cholagogues and choleretics, Gastroenterology, 0302 clinical medicine, Cholagogue, Pathology, Histological progression, Treatment outcome, Child, Hepatic encephalopathy, Prognosis, Ursodeoxycholic acid, Multicenter study, Clinical trial, Retrospective study, Cirrhosis, Biochemical response, Primary biliary cirrhosis, liver, autoimmune, human, 030220 oncology & carcinogenesis, Predictive value of tests, Risk stratification, Disease Progression, Dose-response relationship, drug, Cohort studies, 030211 gastroenterology & hepatology, Cohort analysis, Human, medicine.medical_specialty, Sex factor, Cholangitis, Biliary Liver Cirrhosis, Obeticholic Acid, Major clinical study, Article, Adverse outcome, 03 medical and health sciences, Age, Severity of illness, Dose response, Humans, Disease exacerbation, Survival analysis, Confidence interval, Biliary cirrhosis, Follow up, Globe, digestive system diseases, Event free survival, United States, Retrospective studies, International cooperation, Gastroenterology & hepatology, Internationality, Survival, Middle aged, Priority journal, Risk assessment, Liver Cirrhosis, Biliary, Ascites, Validation study, Europe, Female, France, Sex factors, Age factors, medicine.drug, Adult, Canada, Proportional hazards models, Adolescent, Kaplan-Meier estimate, Hazard ratio, Placebo-controlled trial, Predictive value, macromolecular substances, Outcomes, Proportional hazards model, Internal medicine, medicine, Mortality, Hepatology, business.industry, Drug administration, Bleeding, Drug administration schedule, Retrospective cohort study, Severity of illness index, Spain, Bezafibrate, business, Prediction, Controlled study

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa31e4c2ee652580a21988a89852b6e
http://hdl.handle.net/11452/29979

المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri., orcid:0000-0001-8126-2413, Eren, Fatih, AAS-6286-2020, 12545949900

مصطلحات موضوعية: Placebo-controlled trial, Biochemical response, Histological progression, Cirrhosis, Bezafibrate, Prediction, Prognosis, Survival, Outcomes, Globe, Gastroenterology & hepatology, Adult, Age factors, Cholagogues and choleretics, Disease Progression, Dose-response relationship, drug, Drug administration schedule, Female, Humans, Internationality, Kaplan-Meier estimate, Liver Cirrhosis, Biliary, Male, Middle aged, Predictive value of tests, Proportional hazards models, Retrospective studies, Risk Assessment

Relation: Makale - Uluslararası Hakemli Dergi; American Journal of Gastroenterology; Yurt dışı; Sanayi; Yurt içi; Efe, C. vd. (2019). ''Validation of risk scoring systems in ursodeoxycholic acid-treated patients with primary biliary Cholangitis''. American Journal of Gastroenterology, 114(7), 1101-1108.; https://doi.org/10.14309/ajg.0000000000000290; https://journals.lww.com/ajg/Fulltext/2019/07000/Validation_of_Risk_Scoring_Systems_in.20.aspx; http://hdl.handle.net/11452/29979; 000476563000018; 2-s2.0-85069274453; 1101; 1108; 114

الاتاحة: http://hdl.handle.net/11452/29979
https://doi.org/10.14309/ajg.0000000000000290
https://journals.lww.com/ajg/Fulltext/2019/07000/Validation_of_Risk_Scoring_Systems_in.20.aspx

المؤلفون: M. H. Harms, W. J. Lammers, D. Thorburn, C. Corpechot, P. Invernizzi, H. L. A. Janssen, P. M. Battezzati, F. Nevens, K. D. Lindor, A. Floreani, C. Y. Ponsioen, M. J. Mayo, G. N. Dalekos, T. Bruns, A. Parés, A. L. Mason, X. Verhelst, K. V. Kowdley, J. C. Goet, G. M. Hirschfield, B. E. Hansen, H. R. van Buuren

المساهمون: M.H. Harm, W.J. Lammer, D. Thorburn, C. Corpechot, P. Invernizzi, H.L.A. Janssen, P.M. Battezzati, F. Neven, K.D. Lindor, A. Floreani, C.Y. Ponsioen, M.J. Mayo, G.N. Daleko, T. Brun, A. Paré, A.L. Mason, X. Verhelst, K.V. Kowdley, J.C. Goet, G.M. Hirschfield, B.E. Hansen, H.R. van Buuren

مصطلحات موضوعية: Randomized controlled-trial, biochemical response, natural-history, histological progression, follow-up, prognostic indicator, alkaline-phosphatase, portal-hypertension, cirrhosi, survival, Settore MED/12 - Gastroenterologia, Settore MED/09 - Medicina Interna

Relation: info:eu-repo/semantics/altIdentifier/pmid/29231188; info:eu-repo/semantics/altIdentifier/wos/WOS:000425936500017; volume:113; issue:2; firstpage:254; lastpage:264; numberofpages:11; journal:THE AMERICAN JOURNAL OF GASTROENTEROLOGY; http://hdl.handle.net/2434/629657; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042464929

الاتاحة: http://hdl.handle.net/2434/629657
https://doi.org/10.1038/ajg.2017.440